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Correction to: Nature Communications; https://doi.org/10.1038/s41467-018-06649-5; published online: 14 November 2018
The original version of this Article contained an error in the spelling of the authors Fan Liu and M. Arfan Ikram, which were
incorrectly given as Fan Lui and Arfan M. Ikram.
Furthermore the original version of this Article contained errors in the author afﬁliations.
Peter Kraft was incorrectly associated with Department of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin and
Bren Simon Cancer Center, Indiana University, Indianapolis, IN 63110, USA.
Fan Liu was incorrectly associated with Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston 02115 MA,
USA.
M. Arfan Ikram was incorrectly associated with Department of Genetic Identiﬁcation, Erasmus MC, University Medical Centre,
Rotterdam, The Netherlands.
Pamela A. Madden, Andrew C. Heath and Elliot C. Nelson were incorrectly associated with Department of Internal Medicine, Erasmus
MC, Rotterdam, Netherlands.
Adele C. Green was incorrectly associated with Department of Psychiatry, Washington University School of Medicine, St. Louis, MO
63110, USA.
Stephen Chanock was incorrectly associated with Molecular Oncology Group, CRUK Manchester Institute, University of Manchester,
Manchester, UK
Richard A. Sturm was incorrectly associated with Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda,
MD, USA.
Manfred Kayser was incorrectly associated with Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston
02115 MA, USA.
David J. Hunter was incorrectly associated with Department of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin
and Bren Simon Cancer Center, Indiana University, Indianapolis, IN 63110, USA
Jiali Han was incorrectly associated with Dermatology Research Centre, University of Queensland Diamantina Institute, Translational
Research Institute, Brisbane, Australia
The afﬁliation of André G. Uitterlinden with Department of Internal Medicine, Erasmus MC, Rotterdam, Netherlands was inad-
vertently omitted.
https://doi.org/10.1038/s41467-018-08078-w OPEN
Correspondence and requests for materials should be addressed to D.L.D. (email: David.Duffy@qimrberghofer.edu.au).
#A full list of authors and their afﬁliations appears at the end of the paper.
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Afﬁliation 5 incorrectly read ‘Department of Dermatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands’ and
Afﬁliation 10 incorrectly read ‘Department of Genetic Identiﬁcation, Erasmus MC, University Medical Centre, Rotterdam, The
Netherlands.’
This has now been corrected in both the PDF and HTML versions of the Article.
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